Junfeng Liu
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
- Neurology top 5%
- Intracerebral and Subarachnoid Hemorrhage Research
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disease Mechanisms and Treatments
Papers in
-
- Venous Thromboembolism Diagnosis and Management 13
- Neurology 49
- Intracerebral and Subarachnoid Hemorrhage Research 37
Junfeng Liu
104 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 98
- Internal Medicine 88
- Neurology 344
- Neurology 174
- Epidemiology 524
- Ophthalmology 107
Countries citing papers authored by Junfeng Liu
This map shows the geographic impact of Junfeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Liu more than expected).
Fields of papers citing papers by Junfeng Liu
This network shows the impact of papers produced by Junfeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Liu. The network helps show where Junfeng Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junfeng Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 1 | |
| 8 | Astragaloside IV Ameliorates Streptozotocin Induced Pancreatic β-Cell Apoptosis and Dysfunction Through SIRT1/P53 and Akt/GSK3β/Nrf2 Signaling Pathways | 2022 | 12 |
| 9 | 2022 | 5 | |
| 10 | 2022 | 13 | |
| 11 | 2021 | 14 | |
| 12 | 2021 | 16 | |
| 13 | 2020 | 16 | |
| 14 | 2020 | 37 | |
| 15 | 2017 | 5 | |
| 16 | 2016 | 17 | |
| 17 | 2016 | 0 | |
| 18 | 2016 | 2 | |
| 19 | 2015 | 22 | |
| 20 | 2012 | 60 |
About Junfeng Liu
Junfeng Liu is a scholar working on Internal Medicine, Neurology, Epidemiology, Ophthalmology and Rehabilitation, having authored 107 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (58 papers), Intracerebral and Subarachnoid Hemorrhage Research (37 papers), Cerebrovascular and Carotid Artery Diseases (17 papers), Retinal Imaging and Analysis (13 papers), Venous Thromboembolism Diagnosis and Management (13 papers), Glaucoma and retinal disorders (12 papers), Atrial Fibrillation Management and Outcomes (9 papers) and Stroke Rehabilitation and Recovery (7 papers). The work is most often cited by research in Internal Medicine (88 citations), Neurology (344 citations), Neurology (174 citations), Epidemiology (524 citations) and Ophthalmology (107 citations). Junfeng Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Ming Liu, Wendan Tao, Ming Liu, Deren Wang, Chenchen Wei, Yanan Wang, Bo Wu, Hugh S. Markus, Quhong Song and Yajun Cheng. Their work appears in journals such as Frontiers in Aging Neuroscience, Frontiers in Neurology, BMC Neurology, Journal of Stroke and Cerebrovascular Diseases and Current Neurovascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.